MicroRNA-124 and microRNA-146a both attenuate persistent neuropathic pain induced by morphine in male rats

Brain Res. 2018 Aug 1:1692:9-11. doi: 10.1016/j.brainres.2018.04.038. Epub 2018 May 1.

Abstract

We have recently reported that a short course of morphine, starting 10 days after sciatic chronic constriction injury (CCI), prolonged the duration of mechanical allodynia for months after morphine ceased. Maintenance of this morphine-induced persistent sensitization was dependent on microglial reactivity and Toll-like receptor 4 signaling. Given that microRNAs (miRNAs) such as miR-124 and miR-146a possess the ability to modulate such signaling, we directly compared their function in this model. We found that both miRNAs reversed established allodynia in our model of morphine-induced persistent sensitization. The efficacy of miR-124 and miR-146a were comparable, and in both cases allodynia returned within hours to days of miRNA dosing conclusion. Our findings demonstrate that miRNAs targeting Toll-like receptor signaling are effective in reversing neuropathic pain, which underscores the clinical potential of these non-coding RNAs.

Keywords: Danger signals; Opioid-induced hyperalgesia; P2X7R; Priming; TLR4.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / adverse effects*
  • Analgesics, Opioid / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Disease Models, Animal
  • Hyperalgesia / drug therapy
  • Hyperalgesia / etiology
  • Male
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • MicroRNAs / therapeutic use*
  • Morphine / adverse effects*
  • Morphine / therapeutic use
  • Neuralgia / drug therapy
  • Neuralgia / physiopathology*
  • Pain Threshold / drug effects
  • Rats
  • Rats, Inbred F344

Substances

  • Analgesics, Opioid
  • Anti-Inflammatory Agents
  • MIRN124 microRNA, rat
  • MIRN146 microRNA, rat
  • MicroRNAs
  • Morphine